Clal Biotechnology Industries (TASE: CBI) is Israel’s largest life sciences investment company. CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions, addressing unmet medical needs with multibillion dollar market potential.
With offices in Tel-Aviv and Boston, we provide our companies access to the global biotechnology industry.
We invest in companies ranging from seed to maturity, both public and private. We apply diverse models of strategic cooperation, providing significant investments together with hands-on leadership and guidance.
Clal Industries Ltd. is one of Israel’s leading investment companies. It holds a portfolio of investments from heavy industry to biotechnology, hi-tech and energy companies. Clal Industries is fully owned by Access Industries, a privately held industrial group with long-term holdings worldwide.